Bon Health review
Both molecules cost the same, four term lengths are published, and the coverage list runs to every state.
The verdict
Bon Health publishes $170 a month for either molecule across 50 states, read August 2026. Four term lengths are published beside it, which is more structure than most compounded sellers publish.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 50
- From
- $170/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
Bon Health sells compounded semaglutide and compounded tirzepatide by injection. Both carry the same monthly figure. Coverage is recorded in all fifty states.
Who writes the prescription, and what do they see?
A prescription is issued before shipping and the pages name terms rather than clinicians. The intake is not described anywhere this desk could read. The pricing structure is documented in detail; the clinical one is not documented at all.
Remote, with the commitment length as the main variable a buyer chooses. Four terms are offered and the monthly figure moves with the length rather than with the molecule.
What happens when the dose goes up?
Nothing is published about what the figure does at a higher dose, and the term structure makes that gap matter more. A buyer choosing the longest term fixes a commitment across an escalation whose cost behavior is unstated.
What the price includes
$170 is the figure at the shortest term, and the same number covers either molecule — unusual, since tirzepatide carries a premium almost everywhere else here. Six months is $1,020 at that rate. The longer terms publish lower monthly figures and buy them with a longer lock.
What it claims, and what it cites
Both lines are compounded, not manufactured. A pharmacy prepares them and the FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Coverage recorded in all fifty states
- Strength: Both molecules at the same figure
- Strength: Four term lengths published, not one
- Limitation: The lower figures require longer locks
- Limitation: No dose behavior published anywhere
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about Bon Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer in a state few sellers reach who wants tirzepatide without the usual premium.
- Wrong for
- A buyer unwilling to trade term length for a lower monthly figure.
How Bon Health compares
| Seller | Who it suits | Go |
|---|---|---|
| Citizen Meds | Readers who want the escalation named up front rather than discovered on a statement | See Citizen Meds → |
| Coivas | Readers comparing headline figures who will ask about dose and coverage before ordering | See Coivas → |
More GLP-1 telehealth sellers reviews: LumoraLuvo HealthLVNG RXMadeMedMagnolia Regenerative MedicineMANÜ Telehealth
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is tirzepatide more expensive here?
- No. Both molecules are $170 a month at the shortest term, read August 2026, which is rare among compounded sellers.
- How do the four terms differ?
- The monthly figure falls as the term lengthens. The trade is a longer commitment for a lower rate, and the structure is published rather than hidden.
- Where does Bon Health ship?
- All fifty states are recorded in its coverage list.
- Is Bon Health legit?
- Bon Health is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is Bon Health expensive compared with other GLP-1 telehealth sellers?
- Bon Health publishes a starting figure of $170/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Bon Health below the median, toward the cheaper end. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.